Example: Heart Attack

Clinical Trials on Chondrosarcoma

Total 93 results

NCT03776942

Completed

Synovial Chondrosarcoma: a Single Institution Experience

Conditions: Synovial Chondrosarcoma
NCT03173976

Recruiting

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

Conditions: Chondrosarcoma
NCT01330966

Completed

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Conditions: Chondrosarcoma; Metastatic Chondrosarcoma
NCT01182753

Recruiting

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base

Conditions: Chondrosarcoma
NCT02008019

Suspended

A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas

Conditions: Chondrosarcoma
NCT04305548

Not yet recruiting

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Conditions: Mesenchymal Chondrosarcoma
NCT04098887

Withdrawn

Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma

Conditions: Metastatic Chondrosarcoma
NCT00496522

Active, not recruiting

Proton Beam Therapy for Chondrosarcoma

Conditions: Chondrosarcoma
NCT00543712

Terminated

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Conditions: Chondrosarcoma
NCT04340843

Recruiting

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

Conditions: Metastatic Primary Central Chondrosarcoma; Unresectable Primary Central Chondrosarcoma
NCT01310816

Completed

A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma

Conditions: Conventional Chondrosarcoma
NCT02996747

Completed

Low Grade Chondrosarcoma Versus Enchondroma

Conditions: Chondroma; Chondrosarcoma
NCT04278781

Recruiting

AG-120 in People With IDH1 Mutant Chondrosarcoma

Conditions: Chondrosarcoma; Chondrosarcoma, Grade 2; Chondrosarcoma, Grade 3; IDH1 Gene Mutation
NCT00797602

Completed

Proton Therapy for Chordomas and/or Chondrosarcomas

Conditions: Chordomas; Chondrosarcomas
NCT01449149

Active, not recruiting

Proton Radiation for Chordomas and Chondrosarcomas

Conditions: Chordomas; Chondrosarcomas
NCT00592748

Completed

Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine

Conditions: Chordoma; Chondrosarcoma
NCT00928525

Unknown status

Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Conditions: Advanced Desmoid Tumor; Advanced Chondrosarcoma
NCT02066285

Active, not recruiting

Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma

Conditions: Solitary Fibrous Tumor; Extraskeletal Myxoid Chondrosarcoma
NCT02821507

Recruiting

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Conditions: Conventional Chondrosarcoma; Myxoid Liposarcoma; Mesenchymal Chondrosarcoma; Dedifferentiated Chondrosarcoma
NCT04458922

Recruiting

Testing Atezolizumab in Patients >= 2 Years Old With Newly Diagnosed, Unresectable, or Metastatic Clear Cell Sarcoma or Chondrosarcoma

Conditions: Chondrosarcoma NCI Grade 2; Chondrosarcoma NCI Grade 3; Clear Cell Sarcoma of Soft Tissue; Dedifferentiated Chondrosarcoma; Primary Central Chondrosarcoma
NCT00107419

Completed

S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma

Conditions: Sarcoma
NCT00096213

Completed

S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone

Conditions: Sarcoma
NCT01267955

Active, not recruiting

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Conditions: Clear Cell Chondrosarcoma; Dedifferentiated Chondrosarcoma; Locally Advanced Chondrosarcoma; Mesenchymal Chondrosarcoma; Metastatic Chondrosarcoma; Primary Central Chondrosarcoma; Unresectable Primary Central Chondrosarcoma
NCT04260113

Active, not recruiting

Apatinib for Inoperable Advanced Chondrosarcoma

Conditions: Efficacy; Toxicity, Drug
NCT02496741

Completed

Metformin And Chloroquine in IDH1/2-mutated Solid Tumors

Conditions: Glioma; Cholangiocarcinoma; Chondrosarcoma